Assessment of the effect of levothyroxine on benign thyroid nodule volume
Phase 2
- Conditions
- Thyroid nodule.Disorders of thyroid glandE00-E07
- Registration Number
- IRCT2015091424021N1
- Lead Sponsor
- Guilan University of Medical Sciences Vice Chancellor for Research
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
patiens with single or multi thyroid nodules that have been proved to be benign with FNA
Exclusion criteria:age under 20 and over 60; hypo or hyper thyroidism; history of using levothyroxine during past year; pregnancy; cardiovascular disease
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Thyroid nodule volume. Timepoint: beginning of assessment,6 months later, 12 months later. Method of measurement: ultrasound.
- Secondary Outcome Measures
Name Time Method TSH. Timepoint: before intervention, 6 weeks later, then every 3 months. Method of measurement: laboratory kit.